journal article·2022-10-20Open access

Overview of Physicochemical Properties of Nanoparticles as Drug Carriers for Targeted Cancer Therapy

Vugar Yagublu, Aynura Karimova, Javahir Hajibabazadeh, Christoph Reissfelder, Mustafa Muradov, Stefano Bellucci, Adil Allahverdiyev

Abstract

The advent of nanotechnology has brought about revolutionary innovations in biological research techniques and medical practice. In recent years, various “smart” nanocarriers have been introduced to deliver therapeutic agents specifically to the tumor tissue in a controlled manner, thereby minimizing their side effects and reducing both dosage and dosage frequency. A large number of nanoparticles have demonstrated initial success in preclinical evaluation but modest therapeutic benefits in the clinical setting, partly due to insufficient delivery to the tumor site and penetration in tumor tissue. Therefore, a precise understanding of the relationships betweenthe physicochemical properties of nanoparticles and their interaction with the surrounding microenvironment in the body is extremely important for achieving higher concentrations and better functionality in tumor tissues. This knowledge would help to effectively combine multiple advantageous functions in one nanoparticle. The main focus of the discussion in this review, therefore, will relate to the main physicochemical properties of nanoparticles while interacting within the body and their tuning potential for increased performance.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Surgery, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany

Nanoresearch Laboratory, Baku State University, AZ 1148 Baku, Azerbaijan

Istituto Nazionale di Fisica Nucleare—Laboratori Nazionali di Frascati, Via E. Fermi 54, 00044 Frascati, Italy

Vali Akhundov National Scientific Research Medical Prophylactic Institute, AZ 1065 Baku, Azerbaijan

References (80)

Show source-provided references
1. Nanoparticles in Biomedical Applications and Their Safety Concerns
2. Nanoparticles in biomedical applications
3. The Importance of Nanotechnology in Biomedical Sciences10.4172/2155-952X.1000105e ↗
4. Synthesis and processing of magnetic nanoparticles10.1016/j.coche.2015.01.003 ↗
5. Superparamagnetic nanoparticles for biomedical applications10.1039/C9TB01955C ↗
6. Nag, O.K., and Delehanty, J.B. (2019). Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery. Pharmaceutics, 11.10.3390/pharmaceutics11100543 ↗
7. Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles10.1016/j.cis.2011.04.003 ↗
8. Editorial: Progress in applications of magnetic nanoparticles in biomedicine
9. Surendran, S.P., Moon, M.J., Park, R., and Jeong, Y.Y. (2018). Bioactive Nanoparticles for Cancer Immunotherapy. Int. J. Mol. Sci., 19.10.3390/ijms19123877 ↗
10. Immunoengineering: How nanotechnology can enhance cancer immunotherapy10.1016/j.cell.2015.03.037 ↗
11. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent10.3109/03639041003710151 ↗
12. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents10.1039/C1CS15248C ↗
13. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement10.1021/la903566y ↗
14. Polyethyleneimine-Coated Manganese Oxide Nanoparticles for Targeted Tumor PET/MR Imaging10.1021/acsami.8b12355 ↗
15. Overview of the optical properties of fluorescent nanoparticles for optical imaging10.4081/ejh.2017.2830 ↗
16. Nanoparticles for biomedical imaging10.1517/17425240903229031 ↗
17. Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation10.1002/adhm.201300617 ↗
18. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
19. Gromnicova, R., Kaya, M., Romero, I.A., Williams, P., Satchell, S., Sharrack, B., and Male, D. (2016). Transport of Gold Nanoparticles by Vascular Endothelium from Different Human Tissues. PLoS ONE, 11.10.1371/journal.pone.0161610 ↗
20. Mechanistic understanding of nanoparticles’ interactions with extracellular matrix: The cell and immune system10.1186/s12989-017-0199-z ↗
21. Hansen, U., Allen, J.M., White, R., Moscibrocki, C., Bruckner, P., Bateman, J.F., and Fitzgerald, J. (2012). WARP interacts with collagen VI-containing microfibrils in the pericellular matrix of human chondrocytes. PLoS ONE, 7.10.1371/journal.pone.0052793 ↗
22. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery10.1016/j.jconrel.2010.08.027 ↗
23. Characterization techniques for nanoparticles: Comparison and complementarity upon studying nanoparticle properties10.1039/C8NR02278J ↗
24. Ankamwar, B. (2012). Size and Shape Effect on Biomedical Applications of Nanomaterials. Biomedical Engineering-Technical Applications in Medicine, IntechOpen.10.5772/46121 ↗
25. Insight into cellular uptake and intracellular trafficking of nanoparticles10.1186/s11671-018-2728-6 ↗
26. Effects of nanomaterial physicochemical properties on in vivo toxicity10.1016/j.addr.2009.03.010 ↗
27. Size-dependent cellular uptake and localization profiles of silver nanoparticles10.2147/IJN.S201107 ↗
28. Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats10.2217/17435889.3.5.703 ↗
29. Size-Dependent Regulation of Intracellular Trafficking of Polystyrene Nanoparticle-Based Drug-Delivery Systems10.1021/acsami.7b05383 ↗
30. Nanoparticles: Cellular uptake and cytotoxicity10.1007/978-94-017-8739-0_5 ↗
31. Cytotoxicity of nanoparticles10.1002/smll.200700595 ↗
32. Physical Properties of Nanoparticles That Result in Improved Cancer Targeting10.1155/2020/5194780 ↗
33. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction10.2217/nnm.16.5 ↗
34. Understanding biophysicochemical interactions at the nano-bio interface10.1038/nmat2442 ↗
35. Toxicity and cellular uptake of gold nanoparticles: What we have learned so far?10.1007/s11051-010-9911-8 ↗
36. Huang, Y.W., Cambre, M., and Lee, H.J. (2017). The Toxicity of Nanoparticles Depends on Multiple Molecular and Physicochemical Mechanisms. Int. J. Mol. Sci., 18.10.3390/ijms18122702 ↗
37. Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane10.1073/pnas.1200718109 ↗
38. Renal clearance of quantum dots10.1038/nbt1340 ↗
39. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: The role of cellular uptake, agglomeration and Ag release10.1186/1743-8977-11-11 ↗
40. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
41. Influence of Size and Shape on the Biodistribution of Nanoparticles Prepared by Polymerization-Induced Self-Assembly10.1021/acs.biomac.7b00995 ↗
42. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications10.7150/thno.23459 ↗
43. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking10.1002/smll.201201390 ↗
44. Anisotropic nanomaterials for shape-dependent physicochemical and biomedical applications10.1039/C9CS00011A ↗
45. Shape of nanoparticles as a design parameter to improve docetaxel antitumor efficacy10.1021/acs.bioconjchem.8b00059 ↗
46. The shape effect of PEGylated mesoporous silica nanoparticles on cellular uptake pathway in Hela cells10.1016/j.micromeso.2012.05.040 ↗
47. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells10.1021/nl052396o ↗
48. Endocytosis and exocytosis of nanoparticles in mammalian cells
49. Impact of cerium oxide nanoparticles shape on their in vitro cellular toxicity10.1016/j.tiv.2016.09.022 ↗
50. Rod-shaped iron oxide nanoparticles are more toxic than sphere-shaped nanoparticles to murine macrophage cells10.1002/etc.2735 ↗
51. Shape effect in cellular uptake of PEGylated nanoparticles: Comparison between sphere, rod, cube and disk10.1039/C5NR02970H ↗
52. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles10.1021/nn100816s ↗
53. Cellular uptake of densely packed polymer coatings on gold nanoparticles10.1021/nn9011237 ↗
54. Research highlights: Investigating the role of nanoparticle surface charge in nano-bio interactions10.1039/C7EN90014G ↗
55. Factors influencing the cytotoxicity of zinc oxide nanoparticles: Particle size and surface charge10.1088/1742-6596/304/1/012044 ↗
56. Cytotoxic effects and the mechanism of three types of magnetic nanoparticles on human hepatoma BEL-7402 cells10.1186/1556-276X-6-480 ↗
57. Interactions between Janus particles and membranes10.1039/C1NR11425E ↗
58. Computational investigation of interaction between nanoparticles and membranes: Hydrophobic/hydrophilic effect10.1021/jp8051906 ↗
59. Guerrini, L., Alvarez-Puebla, R.A., and Pazos-Perez, N. (2018). Surface modifications of nanoparticles for stability in biological fluids. Materials, 11.10.3390/ma11071154 ↗
60. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding10.1021/la052797j ↗
61. Coating Metal Nanoparticle Surfaces with Small Organic Molecules Can Reduce Nonspecific Cell Uptake10.1021/acsnano.7b03025 ↗
62. Reduction of pulmonary toxicity of metal oxide nanoparticles by phosphonate-based surface passivation
63. Comparison of toxicity of uncoated and coated silver nanoparticles10.1088/1742-6596/429/1/012025 ↗
64. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system10.1016/j.biomaterials.2013.07.102 ↗
65. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment10.1039/C1CS15233E ↗
66. The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study
67. Understanding the nanoparticle-protein corona using methods to quntify exchange rates and affinities of proteins for nanoparticles10.1073/pnas.0608582104 ↗
68. Physical-Chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles10.1021/ja107583h ↗
69. Adsorption of proteins on gold nanoparticles: One or more layers?10.1016/j.colsurfb.2018.10.025 ↗
70. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis10.1021/nn201950e ↗
71. Barbero, F., Russo, L., Vitali, M., Piella, J., Salvo, I., Borrajo, M.L., Busquets-Fité, M., Grandori, R., Bastús, N.G., and Casals, E. (2017). Formation of the protein corona: The interface between nanoparticles and the immune system. Seminars in Immunology, Academic Press.10.1016/j.smim.2017.10.001 ↗
72. Protein corona-enabled systemic delivery and targeting of nanoparticles10.1208/s12248-020-00464-x ↗
73. Strategy for Avoiding Protein Corona Inhibition of Targeted Drug Delivery by Linking Recombinant Affibody Scaffold to Magnetosomes10.2147/IJN.S338349 ↗
74. Understanding the relevance of protein corona in nanoparticle-based therapeutics and diagnostics10.1039/D0RA05241H ↗
75. What the cell “sees” in bionanoscience10.1021/ja910675v ↗
76. Shannahan, J.H., Lai, X., Ke, P.C., Podila, R., Brown, J.M., and Witzmann, F.A. (2013). Silver Nanoparticle Protein Corona Composition in Cell Culture Media. PLoS ONE, 8.10.1371/journal.pone.0074001 ↗
77. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns10.1080/10611860500071292 ↗
78. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology10.1038/nnano.2013.181 ↗
79. The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles10.1039/B914875B ↗
80. Nanoparticle interaction with the immune system